Filing Details
- Accession Number:
- 0000950170-25-039073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-13 21:51:29
- Reporting Period:
- 2025-03-11
- Filing Date:
- 2025-03-13
- Accepted Time:
- 2025-03-13 21:51:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531177 | Sight Sciences Inc. | SGHT | Surgical & Medical Instruments & Apparatus (3841) | 800625749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2042497 | K. Manohar Raheja | C/O Sight Sciences, Inc. 4040 Campbell Ave., Suite 100 Menlo Park CA 94025 | Evp, Research & Development | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-11 | 24,000 | $0.00 | 135,000 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-03-12 | 10,000 | $2.73 | 145,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-13 | 10,000 | $2.60 | 155,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing January 15, 2026 and continuing through January 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the greater of (i) the closing price of the Common Stock on the grant date, which was March 11, 2025, or (ii) $5.00, such that the total number of shares of Common Stock underlying the grant of RSUs would not exceed 24,000. The RSUs have no expiration date.
- Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $2.70 to $2.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
